IL1B and COVID-19: The heterozygous genotype of the rs16944 (IL1B) variant and the presence of the A allele showed a significant association with increased susceptibility to severe COVID-19 outcomes, including hospitalization and ICU admission, suggesting a possible contributory role in disease severity.